NDC 80425-0557-01 - Citalopram
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0557
- Requested NDC
- 80425-0557-01
- Package NDCs from labels
- 80425-0557-1, 80425-0557-2, 80425-0557-3, 80425-0557-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2025-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Citalopram - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0557-1 | Citalopram | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 | |
| 80425-0557-2 | Citalopram | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 1 | |
| 80425-0557-3 | Citalopram | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0557-1 | EA - Each | 80425-0557 | 76650329-c6a2-4271-832c-c000176eedf7 | 1 | 2025-12-16 |
| 80425-0557-2 | EA - Each | 80425-0557 | 480a3215-4366-4d78-ac5c-60b62131d279 | 1 | 2025-12-16 |
| 80425-0557-3 | EA - Each | 80425-0557 | 84caa3c3-474f-4729-bfe1-ce72215ff89f | 1 | 2025-12-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Citalopram | CITALOPRAM | Hikma Pharmaceuticals USA Inc. | 29408d84-7b00-4cee-969c-8095f8083ff5 | 2023-07-28 | Boxed warning, Warnings, Adverse reactions | I1E9D14F36 |
| Citalopram Hydrobromide | CITALOPRAM HYDROBROMIDE | Proficient Rx LP | 4eb71151-241a-476e-a495-4a021bc55bda | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | ANDA078216 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Proficient Rx LP | f37cc307-8b7d-4e5c-8beb-cd8779bc86a7 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | 3d70380f-ef97-4de9-a8f8-44ef9ba7e5a7 | 2020-05-13 | Boxed warning, Warnings, Adverse reactions | 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Aphena Pharma Solutions - Tennessee, LLC | 31ddd184-7560-473c-b674-5fa3187c5598 | 2020-04-24 | Boxed warning, Warnings, Adverse reactions | 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | 0867140e-a483-4bf7-8326-4a9730cc9d9d | 2020-04-22 | Boxed warning, Warnings, Adverse reactions | 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Proficient Rx LP | 289c1d5e-902f-47db-85b8-5e1a55ec8684 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 200371 I1E9D14F36 |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | d05f4e71-95f3-4f22-8b01-b21e5c19e0f2 | 2018-07-16 | Boxed warning, Warnings, Adverse reactions | 200371 I1E9D14F36 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.